Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-333.87%EBITDA Margin
VS
Market
Sector
Industry
History
$ 12.03Close
$ 4.13 - $ 14.24 52-Week Range
Ticker Information
Ticker
EYPTCompany Name
EYEPOINT PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQEYEPOINT PHARMACEUTICALS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EYPT - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -173.27M | -333.87% | $ 51.9M |
| 3/31/2025 | $ -144.94M | -258.63% | $ 56.04M |
| 12/31/2024 | $ -129.23M | -298.63% | $ 43.27M |
| 9/30/2024 | $ -102.3M | -223.79% | $ 45.71M |
| 6/30/2024 | $ -85.85M | -170.36% | $ 50.39M |
| 3/31/2024 | $ -77.73M | -155.41% | $ 50.02M |
| 12/31/2023 | $ -69M | -149.94% | $ 46.02M |
| 9/30/2023 | $ -97.43M | -229.13% | $ 42.52M |
| 6/30/2023 | $ -101.98M | -273.17% | $ 37.33M |
| 3/31/2023 | $ -97.78M | -245.72% | $ 39.79M |
Key Performance Insights, Last 5 Years
- EYEPOINT PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDA % stands at -84.83%.
- Over the past 5 years, EYEPOINT PHARMACEUTICALS INC's average EBITDA % has been -185.44%.
- The median EBITDA % for EYEPOINT PHARMACEUTICALS INC during this period was -167.87%
- EYEPOINT PHARMACEUTICALS INC reached its highest EBITDA % over the past 5 years at -82.91%.
- The lowest EBITDA % recorded by EYEPOINT PHARMACEUTICALS INC in the same timeframe -333.87%
EYEPOINT PHARMACEUTICALS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for EYEPOINT PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -30.49M ] / Revenues [ $ 35.94M ]
(=) EBITDA % [ -84.83% ] EYPT - EBITDA Margin, Last 5 years
-333.87%
Minimum
Jun 30, 2025
-82.91%
Maximum
Jun 30, 2021
-185.44%
Average
-167.87%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |